stockrow
Friday 6 November 2026
Export NNOX’s income statement to Excel — free account
Nano-X Imaging Ltd.
NNOX Healthcare Medical Devices
Nano-X Imaging Ltd.’s revenue for fiscal 2025 (year ended December 2025) was $13.0 million, up 15.4% from fiscal 2024.
- Revenue
- +36.7%
- EPS
- −243.5%
- Free cash flow
- −21.4%
- Total debt
- −12.0%
Quarter to June 2026, against a year earlier
0.24
0.01
−4.00%
Follow NNOX
Alert me
Nano-X Imaging Ltd. (NNOX) P/E ratio
Nano-X Imaging Ltd. has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (November 2026) to 0.0× (November 2026) — the current reading is the highest in ten years.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 0.0× | — |
| FY2024 | 0.0× | — |
| FY2023 | 0.0× | — |
| FY2022 | 0.0× | — |
| FY2021 | 0.0× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 0.0× | — |
| Mar 2026 | 0.0× | — |
| Dec 2025 | 0.0× | — |
| Sep 2025 | 0.0× | — |
| 15 more quarters | Free account |
Against its own ten years
Low 0.0×
High 0.0×
Ten-year median
0.0×
Current reading's percentile
100
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| NNOX Nano-X Imaging Ltd. | n/m |
| CTSO Cytosorbents Corporation compare | n/m |
| ALUR Allurion Technologies, Inc. compare | n/m |
| HSCS HeartSciences Inc. compare | n/m |
| PMI Flag Ship Acquisition Corp compare | n/m |
| RBOT Vicarious Surgical Inc. compare | n/m |
| LFWD Lifeward Ltd. compare | n/m |
| ARAY Accuray Incorporated compare | n/m |
| SNWV Sanuwave Health Inc. compare | 1.2× |
| Medical Devices industry median | 24.9× |
| Healthcare sector median | 24.5× |
| Market median | 17.8× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)